CytoSorbents Announces Kathleen P. Bloch To Resume As Full-Time CFO
Portfolio Pulse from Benzinga Newsdesk
CytoSorbents Corporation has announced that Kathleen P. Bloch will resume her role as full-time CFO. Bloch previously served as the company's CFO for 10 years until her retirement in March 2023. She took over as Interim CFO following the investigation and subsequent termination of former CFO Alexander D'Amico.
September 19, 2023 | 11:04 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Kathleen P. Bloch's return as full-time CFO could bring stability to CytoSorbents' financial management after the termination of former CFO Alexander D'Amico.
The return of a seasoned executive like Kathleen P. Bloch to the CFO role could bring stability and confidence to the company's financial management. This could potentially have a positive impact on the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100